VR Logo

Cipla Ltd.


Healthcare | Drugs & Pharma

we think vacations are for wimps

40 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Incorporated: 1935

Chairman: Y K Hamied

Managing Director: Umang Vohra

Group: Cipla

Listing: NSE: CIPLA, BSE: 500087

Headquarters: Mumbai, Maharashtra

Website: www.cipla.com

Key Facts

Market cap: R 64,460.38 Cr

Revenue (TTM): R 18,929.33 Cr

Earnings (TTM): R 2,228.10 Cr

Cash: R 2,020.43 Cr

Total Debt: R 2,816.43 Cr

Promoters' ownership: 36.70%

Liquidity: High

52 Week range: R 355.30 - 878.90

Face value: R2.00

Shares outstanding: 80,64,60,446

10 Years Aggregate:

  • CFO: 17,217.19 Cr
  • EBITDA: 22,903.80 Cr
  • Net Profit: 13,244.30 Cr

Stock Performance

Time Period Cipla S&P BSE Sensex S&P BSE Healthcare
YTD-1.305.63-1.90
1 month-4.49-1.77-2.84
3 months5.6510.600.49
1 Year85.6634.0251.92
3 Years11.8614.7716.25
5 Years8.7315.386.05
10 Years10.1510.5813.72
As on 08-Mar-2021
Year Cipla S&P BSE Sensex S&P BSE Healthcare
202072.2915.7561.45
2019-8.5714.38-3.55
2018-14.555.87-5.89
20176.9827.910.49
2016-13.211.95-12.88
20153.40-5.0315.06
201455.9229.8947.43